Skip to main content

The first fully integrated digital pathology system

General Investment Guidlines

The Lumea Private Fund is designed solely to invest in Lumea, Inc. a digital pathology company that deployed proprietary tissue handling technologies, specimen tracking, laboratory efficiency improvements, a seamless digital signout process, and added invaluable AI and genetic testing partnerships to improve the quality of practices and allows businesses to scale.

Fund Details

$8 million offering

$250,000 minimum investment

5 year Convertible Note with Lumea, Inc.

Yield: 16%* (12% + 30 day SOFR)

Management Fee: 2%

Carry: 20%

Preferred Return/Hurdle: 12%

Convertible at last round or next round with a 25% discount